Tweet
Thank you to everyone who registered to participate in the precisionFDA Truth Challenge V2. We are excited to announce that the PacBio and Oxford Nanopore (Guppy v3.6) datasets for the Truth Challenge V2 are now live, and all the datasets needed to complete the challenge are now available on the challenge site! To accommodate the analysis of these datasets, we have extended the submission deadline for the challenge to June 8th.
-
Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.
The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
...06-02-2026, 10:05 AM -
With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.
Introduction
Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...05-22-2026, 06:42 AM